Cixutumumab and Temsirolimus in Treating Younger Patients With Recurrent or Refractory Sarcoma

Clinical trial NCT01614795 · COMPLETED

Trial details

NCT number: NCT01614795
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Childhood Alveolar Soft Part Sarcoma Childhood Angiosarcoma Childhood Epithelioid Sarcoma Childhood Fibrosarcoma Childhood Gliosarcoma Childhood Leiomyosarcoma Childhood Liposarcoma Childhood Malignant Peripheral Nerve Sheath Tumor Childhood Synovial Sarcoma Previously Treated Childhood Rhabdomyosarcoma Recurrent Childhood Rhabdomyosarcoma Recurrent Childhood Soft Tissue Sarcoma

Start date: 2012-06-18
Primary completion: 2014-04-01
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.